Safety of Ferric Carboxymaltose Immediately after Infliximab Administration, in a Single Session, in Inflammatory Bowel Disease Patients with Iron Deficiency: A Pilot Study

Open Access

Peer-reviewed

Research Article

Xavier Cortes ,

* E-mail: xacori@gmail.com

Affiliations IBD Unit, Gastroenterology Section, Internal Medicine Hospital of Sagunto, Sagunto, Spain, University of Cardenal Herrera-CEU, Castellón, Spain
⨯
Joaquín Borrás-Blasco,

Affiliation Pharmacy Service, Hospital of Sagunto, Sagunto, Spain
⨯
Jose Ramón Molés,

Affiliation IBD Unit, Gastroenterology Section, Internal Medicine Hospital of Sagunto, Sagunto, Spain
⨯
Maia Boscá,

Affiliation IBD Unit, Gastroenterology Department of the University Clinic Hospital of Valencia, Valencia, Spain
⨯
Ernesto Cortés

Affiliation Pharmacology, Paediatrics and Organic Chemistry Department, Miguel Hernández University, San Juan of Alicante, Spain
⨯

Reader Comments (0)

Iron deficiency
Is the Subject Area "Iron deficiency" applicable to this article?

Thanks for your feedback.
Intravenous injections
Is the Subject Area "Intravenous injections" applicable to this article?

Thanks for your feedback.
Iron deficiency anemia
Is the Subject Area "Iron deficiency anemia" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Inflammatory bowel disease
Is the Subject Area "Inflammatory bowel disease" applicable to this article?

Thanks for your feedback.
Outpatient clinics
Is the Subject Area "Outpatient clinics" applicable to this article?

Thanks for your feedback.
Pilot studies
Is the Subject Area "Pilot studies" applicable to this article?

Thanks for your feedback.
Hematology
Is the Subject Area "Hematology" applicable to this article?

Thanks for your feedback.